Gemini Therapeutics, Inc. (GMTX): Price and Financial Metrics
GMTX Price/Volume Stats
| Current price | $13.50 | 52-week high | $14.10 |
| Prev. close | $1.35 | 52-week low | $1.16 |
| Day low | $13.50 | Volume | 6,380 |
| Day high | $14.10 | Avg. volume | 189,291 |
| 50-day MA | $1.68 | Dividend yield | N/A |
| 200-day MA | $1.57 | Market Cap | 584.93M |
GMTX Stock Price Chart Interactive Chart >
Gemini Therapeutics, Inc. (GMTX) Company Bio
Gemini Therapeutics, Inc. operates as a precision medicine company. The Company focuses on dry macular degeneration which is a disease comprised of numerous genetic variants. Gemini Therapeutics serves customers worldwide.
GMTX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -51.79% |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...